{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:40:52Z","timestamp":1776775252760,"version":"3.51.2"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003947","name":"Universidad Nacional de La Plata","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmp.2026.105777","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:28:50Z","timestamp":1774110530000},"page":"105777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Status of therapeutic nuclear medicine in Argentina"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4944-8375","authenticated-orcid":false,"given":"Venecia M.","family":"Calandr\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"C\u00e9dola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9743-2253","authenticated-orcid":false,"given":"Vanesa M.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis H.","family":"Illanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-0556","authenticated-orcid":false,"given":"Cecilia Y.","family":"Chain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmp.2026.105777_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Sig Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105777_b0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1470-2045(24)00135-9","article-title":"[177Lu] Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial","volume":"25","author":"Emmett","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejmp.2026.105777_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.103188","article-title":"The contest between internal and external-beam dosimetry: the Zeno\u2019s paradox of Achilles and the tortoise","volume":"117","author":"Cicone","year":"2024","journal-title":"Phys Med"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105777_b0020","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/S1470-2045(21)00657-4","article-title":"Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose","volume":"23","author":"Lawhn-Heath","year":"2022","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejmp.2026.105777_b0025","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2967\/jnumed.124.269378","article-title":"Rethinking dosimetry: a European perspective","volume":"66","author":"Tran-Gia","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105777_b0030","doi-asserted-by":"crossref","unstructured":"Gear J, Stokke C, Terwinghe C, Gnesin S, Sandstr\u00f6m M, Tran-Gia J, Cremonesi M, Cicone F, Verburg F, Hustinx R, Giovanella L, Herrmann K, Gabi\u00f1a PM. EANM enabling guide: how to improve the accessibility of clinical dosimetry. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):1861-1868. doi: 10.1007\/s00259-023-06226-z. Epub 2023 Apr 22. Erratum in: Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3157-3158. doi: 10.1007\/s00259-023-06304-2. PMID: 37086275; PMCID: PMC10287783.","DOI":"10.1007\/s00259-023-06304-2"},{"key":"10.1016\/j.ejmp.2026.105777_b0035","doi-asserted-by":"crossref","unstructured":"Becker DV, Sawn CT. Radioiodine and thyroid disease: the beginning. In: Seminars in nuclear medicine. WB Saunders, 1996. p. 155-164. doi:10.1016\/S0001-2998(96)80020-1.","DOI":"10.1016\/S0001-2998(96)80020-1"},{"key":"10.1016\/j.ejmp.2026.105777_b0040","doi-asserted-by":"crossref","unstructured":"Peano M, Pedrosa JM. Uso de radiois\u00f3topos en medicina. El rol de la Comisi\u00f3n Nacional de Energ\u00eda At\u00f3mica en su impulso (1950-1982). Asclepio, 2018, 70.1: p212-p212.","DOI":"10.3989\/asclepio.2018.05"},{"key":"10.1016\/j.ejmp.2026.105777_b0045","unstructured":"Instalaciones Clase II\/III que no son del Ciclo del Combustible con Licencia\/Registro de Operaci\u00f3n vigente, https:\/\/www.argentina.gob.ar\/sites\/default\/files\/instalaciones_clase_ii-iii_licencias_y_registros_24-6-2021.pdf [accessed 15 october 2021]."},{"key":"10.1016\/j.ejmp.2026.105777_b0050","unstructured":"Resultados del Censo 2022 en Argentina, https:\/\/censo.gob.ar\/index.php\/datos_definitivos\/, [accessed 15 July 2025]."},{"key":"10.1016\/j.ejmp.2026.105777_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.103196","article-title":"Implementation of dosimetry for molecular radiotherapy; results from a European survey","volume":"117","author":"Peters","year":"2024","journal-title":"Phys Medica"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105777_b0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40658-017-0193-4","article-title":"Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey","volume":"4","author":"Sj\u00f6green Gleisner","year":"2017","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105777_b0065","doi-asserted-by":"crossref","unstructured":"Dewaraja Y, Sj\u00f6green\u2013Gleisner K. Dosimetry for Radiopharmaceutical Therapy, Non-serial Publications, IAEA, Vienna (2024), doi:10.61092\/iaea.xlzb-6h67.","DOI":"10.61092\/iaea.xlzb-6h67"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105777_bib77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0146645319838665","article-title":"ICRP publication 140: radiological protection in therapy with radiopharmaceuticals","volume":"48","author":"Yonekura","year":"2019","journal-title":"Annals of the ICRP"},{"key":"10.1016\/j.ejmp.2026.105777_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.103166","article-title":"EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy\u2013Molecular radiotherapy","volume":"116","author":"Sj\u00f6green-Gleisner","year":"2023","journal-title":"Physica Medica"},{"key":"10.1016\/j.ejmp.2026.105777_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/14736691211060117","article-title":"ICRU report 96, dosimetry-guided radiopharmaceutical therapy","volume":"21","author":"Sgouros","year":"2021","journal-title":"J ICRU"},{"key":"10.1016\/j.ejmp.2026.105777_b0070","series-title":"(SAMIRA study on the implementation of the Euratom and EU legal bases with respect to the therapeutic uses of radiopharmaceuticals","author":"Krause","year":"2024"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105777_b0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40658-020-0282-7","article-title":"EANM dosimetry committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours","volume":"7","author":"Gear","year":"2020","journal-title":"EJNMMI Phys"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:46:20Z","timestamp":1776771980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179726000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":18,"alternative-id":["S1120179726000645"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105777","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Status of therapeutic nuclear medicine in Argentina","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105777"}}